Cargando…
An mRNA SARS-CoV-2 Vaccine Employing Charge-Altering Releasable Transporters with a TLR-9 Agonist Induces Neutralizing Antibodies and T Cell Memory
[Image: see text] The SARS-CoV-2 pandemic has necessitated the rapid development of prophylactic vaccines. Two mRNA vaccines have been approved for emergency use by the FDA and have demonstrated extraordinary effectiveness. The success of these mRNA vaccines establishes the speed of development and...
Autores principales: | Haabeth, Ole A. W., Lohmeyer, Julian J. K., Sallets, Adrienne, Blake, Timothy R., Sagiv-Barfi, Idit, Czerwinski, Debra K., McCarthy, Blaine, Powell, Abigail E., Wender, Paul A., Waymouth, Robert M., Levy, Ronald |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265720/ https://www.ncbi.nlm.nih.gov/pubmed/34341771 http://dx.doi.org/10.1021/acscentsci.1c00361 |
Ejemplares similares
-
Sequential tumor and dual immune targeted immunotherapy: anti-lymphoma activity of Rituximab with 4-1bb stimulation and PD-1 blockade
por: Mueller, Antonia MS, et al.
Publicado: (2014) -
TLR Agonist Therapy of Metastatic Breast Cancer in Mice
por: Klinman, Dennis M., et al.
Publicado: (2023) -
Bioorthogonal Catalysis: A General Method To Evaluate
Metal-Catalyzed Reactions in Real Time in Living Systems Using a Cellular
Luciferase Reporter System
por: Hsu, Hsiao-Tieh, et al.
Publicado: (2015) -
Reversible RNA acylation for control of CRISPR–Cas9 gene editing
por: Habibian, Maryam, et al.
Publicado: (2019) -
Synthesis and mechanistic investigations of pH-responsive cationic poly(aminoester)s
por: Blake, Timothy R., et al.
Publicado: (2020)